Papers
2
Total Citations
27
H-Index
2
About
Zoe Zimmermann is a leading clinical researcher at the frontier of neuro-oncology and precision radiotherapy, with a focused expertise in the management of optic nerve sheath meningiomas (ONSM). Her work has been instrumental in advancing the safety and efficacy of robotic radiosurgery (RRS) for these rare, vision-threatening tumors. In her landmark 2021 study, she demonstrated the effectiveness of RRS in a single-institution series of 25 patients, providing critical evidence that has helped validate this controversial treatment modality (14 citations). Zimmermann further revolutionized treatment planning by pioneering the use of 68Ga-DOTATOC-PET/MRI as a "one-stop shop" imaging tool for ONSM. Her 2021 paper on this hybrid, receptor-based imaging approach (13 citations) showed how it enhances tumor delineation and diagnostic accuracy, enabling more precise and safer radiosurgical targeting. By integrating advanced molecular imaging with robotic delivery, Zimmermann has set a new standard for minimizing collateral damage to the optic nerve. Her work is widely cited by neurosurgeons and radiation oncologists, and she is recognized as a key authority in translating cutting-edge imaging technology into tangible clinical benefits for patients facing blindness.
Research Focus
Key Achievements
Top Papers
- 1
- 2